Registry of Lobbyists
Version 1 of 1 (1998-03-19 to 1998-06-24) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
BOEHRINGER INGELHEIM (CANADA) LTD.
5180 SOUTH SERVICE ROAD BURLINGTON, ON L7L 5H4 Canada |
| Telephone number: | 905-631-4511 |
| Fax number: | 905-639-9359 |
| Responsible officer name and position during the period of this registration: | PAUL AGRO, EXTERNAL AFFAIRS AND MANAGED CARE |
| Description of activities: | BOEHRINGER INGELHEIM (CANADA) LTD. IS A MEMBER OF THE BOEHRINGER INGELHEIM GROUP, A PRIVATELY HELD INTERNATIONAL PHARMACEUTICAL ORGANIZATION WITH HEADQUARTERS IN INGELHEIM, GERMANY. THE PRODUCT LINE INCLUDES PHARMACEUTICALS, VETERINARY MEDICINES, CHEMICAL AND BAKING PRODUCTS. EIGHTY PERCENT OF ITS BUSINESS IS IN PHARMACEUTICALS - PRIMARILY CARDIOVASCULAR, RESPIRATORY, ANTISPASMOTIC, ANALGESIC AND ANTIVIRAL AGENTS. BICL, LOCATED IN BURLINGTON, ONTARIO, WAS ESTABLISHED IN 1972 AND IS A LEADING HEALTHCARE COMPANY. BICL SPECIALIZES IN THE MARKETING AND DISTRIBUTION OF HUMAN PHARMACEUTICALS, HEALTH FOOD SUPPLEMENTS AND ANIMAL HEALTH PRODUCTS. |
| The client is a subsidiary of the following parent companies: |
BOEHRINGER INGELHEIM GMBH
D-55216 INGELHEIM AM RHEIN Germany |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property |
| Subject Matter: Particulars: | ANY PROPOSALS FOR CHANGE TO DRUG PATENT LEGISLATION (FORMERLY BILL C-91); PATENT MEDICINE PRICES REVIEW BOARD; HEALTH PROTECTION BRANCH (NEW DRUG APPROVAL POLICIES AND ROCESSES), AND MARKET ACCESS ISSUES |